ERK/MAPK signaling and autism spectrum disorders
- PMID: 30447757
- DOI: 10.1016/bs.pbr.2018.09.008
ERK/MAPK signaling and autism spectrum disorders
Abstract
The MAPK pathway is a prominent intracellular signaling pathway regulating various intracellular functions. Components of this pathway are mutated in a related collection of congenital syndromes collectively referred to as neuro-cardio-facio-cutaneous syndromes (NCFC) or Rasopathies. Recently, it has been appreciated that these disorders are associated with autism spectrum disorders (ASD). In addition, idiopathic ASD has also implicated the MAPK signaling cascade as a common pathway that is affected by many of the genetic variants that have been found to be linked to ASDs. This chapter describes the components of the MAPK pathway and how it is regulated. Furthermore, this chapter will highlight the various functions of the MAPK pathway during both embryonic development of the central nervous system (CNS) and its roles in neuronal physiology and ultimately, behavior. Finally, we will summarize the perturbations to MAPK signaling in various models of autism spectrum disorders and Rasopathies to highlight how dysregulation of this pivotal pathway may contribute to the pathogenesis of autism.
Keywords: Autism spectrum disorders; Corticogenesis; ERK; MAP kinase; Neural progenitors; Rasopathies.
© 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism.Curr Drug Targets. 2021;22(9):1071-1086. doi: 10.2174/1389450121666201020155010. Curr Drug Targets. 2021. PMID: 33081671 Review.
-
Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders.PLoS Genet. 2017 Jan 11;13(1):e1006516. doi: 10.1371/journal.pgen.1006516. eCollection 2017 Jan. PLoS Genet. 2017. PMID: 28076348 Free PMC article.
-
Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms.Prog Brain Res. 2018;241:37-62. doi: 10.1016/bs.pbr.2018.09.014. Epub 2018 Oct 25. Prog Brain Res. 2018. PMID: 30447756 Review.
-
The impact of RASopathy-associated mutations on CNS development in mice and humans.Mol Brain. 2019 Nov 21;12(1):96. doi: 10.1186/s13041-019-0517-5. Mol Brain. 2019. PMID: 31752929 Free PMC article. Review.
-
Autism Spectrum Disorder Symptom Profile Across the RASopathies.Front Psychiatry. 2021 Jan 15;11:585700. doi: 10.3389/fpsyt.2020.585700. eCollection 2020. Front Psychiatry. 2021. PMID: 33519543 Free PMC article.
Cited by
-
The Neuroprotection Effects of Exosome in Central Nervous System Injuries: a New Target for Therapeutic Intervention.Mol Neurobiol. 2022 Dec;59(12):7152-7169. doi: 10.1007/s12035-022-03028-6. Epub 2022 Sep 14. Mol Neurobiol. 2022. PMID: 36103108 Review.
-
Chromatin remodeller CHD7 is required for GABAergic neuron development by promoting PAQR3 expression.EMBO Rep. 2021 Jun 4;22(6):e50958. doi: 10.15252/embr.202050958. Epub 2021 Apr 26. EMBO Rep. 2021. PMID: 33900016 Free PMC article.
-
Repurposing Niclosamide as a plausible neurotherapeutic in autism spectrum disorders, targeting mitochondrial dysfunction: a strong hypothesis.Metab Brain Dis. 2024 Mar;39(3):387-401. doi: 10.1007/s11011-023-01247-x. Epub 2023 Jun 7. Metab Brain Dis. 2024. PMID: 37284987 Free PMC article. Review.
-
Transcriptomics of Gabra4 knockout mice reveals common NMDAR pathways underlying autism, memory, and epilepsy.Mol Autism. 2020 Feb 7;11(1):13. doi: 10.1186/s13229-020-0318-9. Mol Autism. 2020. PMID: 32033586 Free PMC article.
-
Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorder.Pharmgenomics Pers Med. 2025 Jan 17;18:1-18. doi: 10.2147/PGPM.S494126. eCollection 2025. Pharmgenomics Pers Med. 2025. PMID: 39850061 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous